Catherine H. Trepanier

发表

Neuroinflammation in Alzheimer's disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy?

N. Milgram, Catherine H. Trepanier, 2010, Journal of Alzheimer's disease : JAD.

VASOACTIVE INTESTINAL PEPTIDE (VIP) ACTS VIA MULTIPLE SIGNAL PATHWAYS TO REGULATE HIPPOCAMPAL NMDA RECEPTORS AND SYNAPTIC TRANSMISSION

J. Macdonald, M. F. Jackson, M. Beazely, 2011 .

Plasticity of synaptic glun receptors is required for the Src‐dependent induction of long‐term potentiation at CA3‐CA1 synapses

B. Orser, J. Macdonald, M. Salter, 2011, Hippocampus.

Platelet-derived Growth Factor Selectively Inhibits NR2B-containing N-Methyl-D-aspartate Receptors in CA1 Hippocampal Neurons*

J. Macdonald, M. Beazely, Catherine H. Trepanier, 2009, Journal of Biological Chemistry.

Modulation of N-methyl-D-aspartate receptors by Gαs- and Gαi/o-coupled receptors

Catherine H. Trepanier, 2013 .

Regulation of NMDA receptors by the tyrosine kinase Fyn

J. Macdonald, M. F. Jackson, Catherine H. Trepanier, 2012, The FEBS journal.

Group II metabotropic glutamate receptors modify N-methyl-D-aspartate receptors via Src kinase

J. Macdonald, Catherine H. Trepanier, Yu-Feng Xie, 2013, Scientific Reports.

Fyn, a potential target for Alzheimer's disease.

Gang Lei, Jillian Belrose, J. Macdonald, 2011, Journal of Alzheimer's disease : JAD.

Infantile Spasms and Down Syndrome: A New Animal Model

O. Snead, M. Cortez, H. Sadeghnia, 2009, Pediatric Research.

Metaplasticity gated through differential regulation of GluN2A versus GluN2B receptors by Src family kinases

B. Orser, J. Macdonald, Tadashi Yamamoto, 2012, The EMBO journal.

Vasoactive intestinal peptide acts via multiple signal pathways to regulate hippocampal NMDA receptors and synaptic transmission

J. Macdonald, M. F. Jackson, M. Beazely, 2009, Hippocampus.